(19)
(11) EP 2 291 351 A1

(12)

(43) Date of publication:
09.03.2011 Bulletin 2011/10

(21) Application number: 08750117.7

(22) Date of filing: 07.05.2008
(51) International Patent Classification (IPC): 
C07C 323/60(2006.01)
C07D 241/20(2006.01)
C07D 277/64(2006.01)
A61K 31/16(2006.01)
A61K 31/415(2006.01)
A61K 31/428(2006.01)
A61K 31/53(2006.01)
A61P 3/10(2006.01)
C07D 231/40(2006.01)
C07D 263/56(2006.01)
C07D 285/135(2006.01)
A61K 31/165(2006.01)
A61K 31/423(2006.01)
A61K 31/433(2006.01)
A61P 3/04(2006.01)
(86) International application number:
PCT/EP2008/055594
(87) International publication number:
WO 2009/135526 (12.11.2009 Gazette 2009/46)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(71) Applicant: Novartis AG
4056 Basel (CH)

(72) Inventors:
  • NAPOLETANO, Mauro
    I-20127 Milano (IT)
  • HAACK, Thomas
    I-22100 Como (IT)
  • TSCHINKE, Vincenzo
    CH-4102 Binningen (CH)
  • JELAKOVIC, Stjepan
    79100 Freiburg (DE)
  • MAH, Robert
    CH-4132 Muttenz (CH)

(74) Representative: von Sprecher, Georg et al
Novartis Pharma AG Patent Department
4002 Basel
4002 Basel (CH)

   


(54) ALPHA-MERCAPTO-AMIDES